Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Priority review granted for Arixtra sNDA

March 6, 2003

Low-dose warfarin reported to prevent recurrent venous thromboembolism

March 4, 2003

CPMP recommends removal of contraindication for i.v. fibrinolytic use in diabetic patients

March 4, 2003

Broad-spectrum antithrombotic properties described for SSR-182289A

Feb. 28, 2003

Nuvelo reveals alfimeprase program progress in 2002

Feb. 27, 2003

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Feb. 27, 2003

Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation

Feb. 20, 2003

Merck designs new factor Xa and/or factor VIIa inhibitors

Feb. 20, 2003

Aventis claims novel factor VIIa inhibitors

Feb. 19, 2003

Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team

Feb. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Combination locked out in ATTR-CM? ‘Dead,’ expert says
BioWorld
The synergy – or lack of it – between knockdown drugs and stabilizers in treating transthyretin (TTR)-mediated amyloid cardiomyopathy (ATTR-CM) became one of the...